Among these, the expression levels of lnc-SENP5-4, lnc-CPSF2-2, and lnc-LRRC47-1 were found to be significantly different in a cohort of 19 MM patients at diagnosis compared to the corresponding relapse/PCL progressed phases (Supplementary Figure S2), a finding that further supports the previous evidence. This evidence concerns the gene CPSF2 and Miyoshi myopathy.